Pay in 4 interest-free payments of $6.15 Learn more
Ships within 48 hours · Estimated delivery Aug 26 - Aug 31
Talk to your GP about hormones For some women, addressing the hormonal root cause is the most effective approach
(10,11) READ MORE: The Best Supplements To Take For Fatty Liver Disease + Natural Strategies To Heal 3
Nice concise review that includes all currently FDA appoved antiobesity medications Obesity pharmacotherapy: approvals and major trial readouts (1999-2025) is very useful I also like a quick comparison table of different medications To view or add a comment, sign in Structure Therapeutics' aleniglipron shows promising weight loss results in Phase II trial aleniglipron Structure Therapeutics obesity Structure Therapeutics' investigational oral GLP-1 candidate, aleniglipron, demonstrated over 11% weight loss in a Phase II trial, leading to a nearly 103% increase in the company's stock price
TrimRxs approach supports this holistic transformation, recognizing that medication is a powerful tool, not a standalone solution
Others: Roche, J&J, Sanofi, and AZ have had GLP-1 efforts (some deprioritized) or new dual/triple agonists in development (e.g., Roches pipeline includes a dual agonist announced in 2024)
They are intended as adjuncts to lifestyle modifications including reduced-calorie diet and increased physical activity, not as standalone treatments
US$ 20.75
US$ 23.57
US$ 24.29
